Saito et al. [15] provided immunologic evidence demonstrating that recovery of Th1 and CD8+ lymphocyte subsets coincided temporally with LPD resolution following MTX discontinuation. This evidence concerns the gene CD8A and disseminated peritoneal leiomyomatosis.